Anti-müllerian hormone levels and antral follicle count in women with a BRCA1 or BRCA2 germline pathogenic variant: A retrospective cohort study
Background: Some studies suggested a decreased ovarian reserve among BRCA1/2 pathogenic variant carriers, with conflicting results. Methods: We conducted a retrospective single-center observational study of ovarian reserve and spontaneous fertility comparing BRCA1/2 pathogenic variant carriers to co...
Main Authors: | Laurie Denis-Laroque, Youenn Drouet, Ingrid Plotton, Nicolas Chopin, Valérie Bonadona, Jacqueline Lornage, Bruno Salle, Christine Lasset, Christine Rousset-Jablonski |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | Breast |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977621004161 |
Similar Items
-
Association of BRCA Mutations and Anti-müllerian Hormone Level in Young Breast Cancer Patients
by: Kyung-A Son, et al.
Published: (2019-04-01) -
Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve
by: Sonal Panchal, et al.
Published: (2012-01-01) -
Anti-mullerian hormone and antral follicle count as predictors of ovarian response in assisted reproduction
by: Y Himabindu, et al.
Published: (2013-01-01) -
Comparison of Automated Anti-Müllerian Hormone Assays and Antral Follicle Count in Predicting Ovarian Response During Ovarian Stimulation
by: Eek Chaw Tan, et al.
Published: (2019-06-01) -
Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
by: Hikmat Abdel-Razeq, et al.
Published: (2018-02-01)